Australia - English - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - ganciclovir sodium, quantity: 543 mg (equivalent: ganciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - indications as at 12 october 2005: cymevene (ganciclovir) administered as the intravenous infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease. note: cymevene (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - ganciclovir sodium -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - ganciclovir sodium 543mg equivalent to 500 mg ganciclovir - powder for infusion - 500 mg - active: ganciclovir sodium 543mg equivalent to 500 mg ganciclovir - iindicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease.

Israel - English - Ministry of Health

tzamal bio-pharma ltd - ganciclovir sodium - solution for injection - ganciclovir sodium 500 mg - ganciclovir - ganciclovir - cymevene iv is indicated for the treatment of cmv retinitis in immunocompromised patiens, including patients with acquired immunodeficiency syndrome (aids). cymevene iv is also indicated for the prevention of cmv disease in transplant recipients at risk for cmv disease.

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - ganciclovir sodium eqv ganciclovir - injection, powder, for solution - 500 mg - ganciclovir sodium eqv ganciclovir 500 mg

Israel - English - Ministry of Health

tzamal bio-pharma ltd - ganciclovir as sodium - powder for solution for infusion - ganciclovir as sodium 500 mg - ganciclovir - cymevene iv is indicated for the treatment of cmv retinitis in immunocompromised patiens, including patients with acquired immunodeficiency syndrome (aids). cymevene iv is also indicated for the prevention of cmv disease in transplant recipients at risk for cmv disease.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

neon healthcare ltd - ganciclovir sodium - powder for solution for infusion - 500mg

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products limited - ganciclovir sodium - pdr/conc/soln for infus - 500 mg milligram - nucleosides and nucleotides excl. reverse transcriptase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - ganciclovir - powder for concentrate for solution for infusion - 500 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; ganciclovir

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pharmaco distribution (pty) ltd - injection - see ingredients - each vial contains ganciclovir sodium equivalent to 500 mg ganciclovir